Skip to content
drillr.ai
Sign up

EQ

Equillium, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.21
−0.45%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue——41.1M36.1M15.8M
Cost of Revenue47.0K116.0K———
Gross Profit(47.0K)(116.0K)41.1M36.1M15.8M
Operating Expenses
R&D Expense8.6M12.8M37.4M37.0M37.5M
SG&A Expense10.7M10.8M11.9M13.6M17.2M
General & Admin Expense10.7M10.8M11.9M13.6M17.2M
Selling & Marketing Expense—————
Other Expenses(47.0K)———23.0M
Total Operating Expenses19.3M23.6M49.4M50.6M77.8M
Cost and Expenses19.3M23.6M49.4M50.6M77.8M
Operating Income (EBIT)(19.3M)(23.6M)(8.3M)(14.5M)(62.1M)
Non-Operating
Interest Income1.4M833.0K1.4M2.3M420.0K
Interest Expense———491.0K1.1M
Net Interest Income1.4M833.0K1.4M1.8M(633.0K)
Other Non-Op Income/Expense1.3M1.2M563.0K1.8M(352.0K)
Non-Operating Income (excl Interest)(878.0K)(1.2M)(563.0K)(2.3M)(701.0K)
EBT (Pre-Tax Income)(18.0M)(22.4M)(7.7M)(12.8M)(62.4M)
Income Tax Expense——361.0K580.0K—
Bottom Line
Net Income(18.0M)(22.4M)(8.1M)(13.3M)(62.4M)
Earnings from Cont. Ops(18.0M)(22.4M)(8.1M)(13.3M)(62.4M)
Earnings from Discont. Ops—————
Bottom Line Net Income(18.0M)(22.4M)(8.1M)(13.3M)(62.4M)
Per Share
Basic EPS($0.26)($0.39)($0.23)($0.38)($3.19)
Diluted EPS($0.26)($0.39)($0.23)($0.38)($3.19)
Revenue Per Share$0.00$0.00$1.16$1.04$0.47
Shares
Basic Shares Outstanding111.8M91.9M35.4M34.7M33.7M
Diluted Shares Outstanding111.8M91.9M35.4M34.7M33.7M
Profitability Metrics
EBITDA(18.3M)(22.3M)(7.6M)(12.1M)(61.3M)
D&A75.0K116.0K137.0K126.0K118.0K
EBIT(18.4M)(22.4M)(7.7M)(12.3M)(61.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026